IP Library › Assignment 046912/0972
Patent Assignment
Reel/Frame 046912/0972

Assignment of Assignor's Interest

Recorded: 2018-09-19 Pages: 5
Assignor
QUANTICEL PHARMACEUTICALS, INC.
Executed: 2018-09-19
Assignee
CELGENE CORPORATION
86 MORRIS AVENUE, SUMMIT, NEW JERSEY, 07901
Covered Properties (3)
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Application: 15/673,084 →
Publication: US 2018/0125844
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Application: 62/373,263 →
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Application: 62/468,424 →
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 19, 2016
From: XU, JIANGCHUN; CHO, ROBERT; NGUYEN, AARON
To: CELGENE CORPORATION
Reel/Frame 039484/0664 →
Assignment of Assignor's Interest Mar 21, 2017
From: XU, JIANGCHUN; CHO, ROBERT; NGUYEN, AARON
To: CELGENE CORPORATION
Reel/Frame 041658/0071 →
Assignment of Assignor's Interest Apr 5, 2018
From: XU, JIANGCHUN; NGUYEN, AARON
To: CELGENE CORPORATION
Reel/Frame 045452/0543 →
Employment Agreement Sep 19, 2018
From: CHO, ROBERT
To: QUANTICEL PHARMACEUTICALS, INC
Reel/Frame 047321/0235 →
Assignment of Assignor's Interest Nov 11, 2019
From: CELGENE CORPORATION
To: CELGENE QUANTICEL RESEARCH, INC.
Reel/Frame 050974/0894 →